Predicting COVID-19 and pneumonia complications from admission texts

Dmitriy Umerenkov,Oleg Cherkashin,Alexander Nesterov,Victor Gombolevskiy,Irina Demko,Alexander Yalunin,Vladimir Kokh
DOI: https://doi.org/10.48550/arXiv.2305.03661
2023-05-05
Computation and Language
Abstract:In this paper we present a novel approach to risk assessment for patients hospitalized with pneumonia or COVID-19 based on their admission reports. We applied a Longformer neural network to admission reports and other textual data available shortly after admission to compute risk scores for the patients. We used patient data of multiple European hospitals to demonstrate that our approach outperforms the Transformer baselines. Our experiments show that the proposed model generalises across institutions and diagnoses. Also, our method has several other advantages described in the paper.
What problem does this paper attempt to address?
### Problems the Paper Attempts to Solve This paper proposes a new method to assess the risk of complications in patients hospitalized due to pneumonia or COVID-19 through admission reports and other textual data. Specifically, the method uses the Longformer neural network to process admission reports and other textual data to calculate the patient's risk score. The main contributions of the paper are as follows: 1. **Using a Pre-trained Longformer Model**: Applying the Longformer model to long medical texts, particularly patients' admission reports and other related textual data. 2. **No Additional Clinical Features Required**: Risk assessment is performed using only the raw textual data without the need for any additional clinical features (such as age, temperature, blood pressure, etc.) as input. 3. **Cross-Institution Robustness**: The model has good generalizability across different medical institutions, allowing it to be quickly deployed to other hospitals after being trained on data from several major hospitals without the need for retraining. 4. **Cross-Disease Generalizability**: The model trained on one disease (such as pneumonia) can be used to assess the risk of another disease (such as COVID-19), although with slightly reduced efficiency. 5. **Practical Validation**: The model has been validated in a hospital environment and has been recognized by doctors as very useful in identifying high-risk cases, especially in situations where it is difficult to judge at the time of admission. Overall, this paper aims to develop a system that can help doctors assess the risk of complications in pneumonia and COVID-19 patients. The system is easy to integrate into existing hospital electronic medical record systems and can handle the diverse forms of medical examinations and diagnostic tests across different medical institutions.